Characterization of a Potent, Selective, and Safe Inhibitor, Ac15(Az8)(2), in Reversing Multidrug Resistance Mediated by Breast Cancer Resistance Protein (BCRP/ABCG2)

Overexpression of breast cancer resistance transporter (BCRP/ABCG2) in cancers has been explained for the failure of chemotherapy in clinic. Inhibition of the transport activity of BCRP during chemotherapy should reverse multidrug resistance. In this study, a triazole-bridged flavonoid dimer Ac15(Az...

Descripción completa

Detalles Bibliográficos
Autores principales: Chong, Tsz Cheung, Wong, Iris L. K., Cui, Jiahua, Law, Man Chun, Zhu, Xuezhen, Hu, Xuesen, Kan, Jason W. Y., Yan, Clare S. W., Chan, Tak Hang, Chow, Larry M. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653733/
https://www.ncbi.nlm.nih.gov/pubmed/36362047
http://dx.doi.org/10.3390/ijms232113261

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653733/
https://www.ncbi.nlm.nih.gov/pubmed/36362047
http://dx.doi.org/10.3390/ijms232113261

Ejemplares similares